Dargen 40mcg Injection

Name: Dargen 40mcg Injection
Brand: PHOENIX PHARMEX
Price: 2300.0 INR
Availability: InStock

Price 2300.0 INR/ Piece

Get a Price/Quote

MOQ : 1 Piece

Dargen 40mcg Injection Specification

Dosage Form
Injection

Pacakaging (Quantity Per Box)
1

Salt Composition
Darbepoetin alfa

Origin of Medicine
India

Indication
Treatment of Anemia in Chronic Kidney Disease (CKD)

Drug Type
Injection

Ingredients
Dargen 40 mcg Injection (PFS) contains darbepoetin alfa, an erythropoiesis-stimulating agent used to treat anemia caused by chronic kidney disease (CKD) in adults and children. It works by stimulating red blood cell production, helping improve hemoglobin levels and reduce symptoms such as fatigue and weakness. Regular blood tests and blood pressure monitoring are required to ensure safe and effective treatment. Dargen is not recommended for patients with uncontrolled hypertension and should be used with caution in individuals with liver disease, seizures, sickle cell anemia, or a history of poor response to anemia therapy. Use during pregnancy should be carefully evaluated, breastfeeding is not advised, and treatment in infants or children should be undertaken only under strict medical supervision.

Physical Form
Liquid

Recommended For
Treatment of Anemia in Chronic Kidney Disease (CKD)

Suitable For
Suitable For All

Dargen 40mcg Injection Trade Information

Minimum Order Quantity
1 Piece

Delivery Time
2 Days

About Dargen 40mcg Injection

Dargen 40 mcg Injection (PFS) contains darbepoetin alfa, an erythropoiesis-stimulating agent used to treat anemia caused by chronic kidney disease (CKD) in adults and children. It works by stimulating red blood cell production, helping improve hemoglobin levels and reduce symptoms such as fatigue and weakness. Regular blood tests and blood pressure monitoring are required to ensure safe and effective treatment.

Dargen is not recommended for patients with uncontrolled hypertension and should be used with caution in individuals with liver disease, seizures, sickle cell anemia, or a history of poor response to anemia therapy. Use during pregnancy should be carefully evaluated, breastfeeding is not advised, and treatment in infants or children should be undertaken only under strict medical supervision.

Tell us about your requirement